Tim Watts, CEO of Shield Therapeutics provides an update on its plans to commercialise Accrufer® in the USA

Episode 96,   Dec 10, 2020, 01:52 PM

Headliner
Share
Subscribe
Tim Watts, CEO of Shield Therapeutics #STX provides an update on its plans to commercialise Accrufer® in the USA and talks about their cash position.
Share
Subscribe
Next
Tony Swiericzuk, CEO of SO4 explains how their equity placing enables the financial close on their debt facility
Top episodes
Is a house price crash coming?
by The Vox Markets Podcast
Alastair Smith of Avacta: Successful Completion of Fourth Dose Escalation in AVA6000 Study
by The Vox Markets Podcast
Vox Markets Interview with Avacta CEO Alastair Smith
by The Vox Markets Podcast
Related episodes
3 Million BMW EVs, New F-150 Lightning STX and Tesla’s Trillion Dollar CEO Gamble | 08 Sep 2025
by EV News Daily - Technology and Business of EVs
Briefly | 08 Sep 2025
by EV News Daily - Technology and Business of EVs
The AIM All Share Hit’s an 11 Month High
by The SharePickers Podcast with Justin Waite